ClinicalTrials.Veeva

Menu

Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Novartis logo

Novartis

Status and phase

Completed
Phase 3

Conditions

Osteoarthritis

Treatments

Drug: Diclofenac Topical Sodium Gel 1%

Study type

Interventional

Funder types

Industry

Identifiers

NCT00171691
VOSG-PN-309

Details and patient eligibility

About

This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.

Sex

All

Ages

35+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion criteria

• Osteoarthritis of the knee

Key Exclusion criteria

  • Other rheumatic disease, such as rheumatoid arthritis
  • Active gastrointestinal ulcer during the last year
  • Known allergy to analgesic drugs

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems